These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 20413731)

  • 1. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.
    Montecucco F; Lenglet S; Braunersreuther V; Pelli G; Pellieux C; Montessuit C; Lerch R; Deruaz M; Proudfoot AE; Mach F
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1371-7. PubMed ID: 20413731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice.
    Braunersreuther V; Montecucco F; Pelli G; Galan K; Proudfoot AE; Belin A; Vuilleumier N; Burger F; Lenglet S; Caffa I; Soncini D; Nencioni A; Vallée JP; Mach F
    Thromb Haemost; 2013 Oct; 110(4):807-25. PubMed ID: 23925450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
    Arslan F; Smeets MB; O'Neill LA; Keogh B; McGuirk P; Timmers L; Tersteeg C; Hoefer IE; Doevendans PA; Pasterkamp G; de Kleijn DP
    Circulation; 2010 Jan; 121(1):80-90. PubMed ID: 20026776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice.
    Braunersreuther V; Pellieux C; Pelli G; Burger F; Steffens S; Montessuit C; Weber C; Proudfoot A; Mach F; Arnaud C
    J Mol Cell Cardiol; 2010 Apr; 48(4):789-98. PubMed ID: 19665464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of erythropoietin to render jeopardized ischemic myocardium amenable to incremental salvage by early reperfusion.
    French CJ; Zaman AK; Sobel BE
    Coron Artery Dis; 2009 Jun; 20(4):295-9. PubMed ID: 19440068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection.
    Tarzami ST; Miao W; Mani K; Lopez L; Factor SM; Berman JW; Kitsis RN
    Circulation; 2003 Nov; 108(19):2387-92. PubMed ID: 14568904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion.
    Montecucco F; Lenglet S; Braunersreuther V; Burger F; Pelli G; Bertolotto M; Mach F; Steffens S
    J Mol Cell Cardiol; 2009 May; 46(5):612-20. PubMed ID: 19162037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin ameliorates the immediate myocardial injury in rat heart transplant through downregulation of neutrophil-dependent myocardial apoptosis.
    Al-Amran F; Shahkolahi M
    Transplant Proc; 2013; 45(6):2506-12. PubMed ID: 23953571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis.
    Montecucco F; Mach F; Lenglet S; Vonlaufen A; Gomes Quinderé AL; Pelli G; Burger F; Galan K; Dallegri F; Carbone F; Proudfoot AE; Vuilleumier N; Frossard JL
    Eur J Clin Invest; 2014 Oct; 44(10):940-50. PubMed ID: 25132144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury.
    Mersmann J; Berkels R; Zacharowski P; Tran N; Koch A; Iekushi K; Dimmeler S; Granja TF; Boehm O; Claycomb WC; Zacharowski K
    Crit Care Med; 2010 Mar; 38(3):903-9. PubMed ID: 20081527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice.
    Montecucco F; Braunersreuther V; Lenglet S; Delattre BM; Pelli G; Buatois V; Guilhot F; Galan K; Vuilleumier N; Ferlin W; Fischer N; Vallée JP; Kosco-Vilbois M; Mach F
    Eur Heart J; 2012 Aug; 33(15):1964-74. PubMed ID: 21606075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits.
    Rao Y; Wang YL; Zhang WS; Liu J
    Anesth Analg; 2008 May; 106(5):1353-9, table of contents. PubMed ID: 18420844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
    Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
    Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury.
    Bao W; Hu E; Tao L; Boyce R; Mirabile R; Thudium DT; Ma XL; Willette RN; Yue TL
    Cardiovasc Res; 2004 Feb; 61(3):548-58. PubMed ID: 14962485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury.
    Roubille F; Combes S; Leal-Sanchez J; Barrère C; Cransac F; Sportouch-Dukhan C; Gahide G; Serre I; Kupfer E; Richard S; Hueber AO; Nargeot J; Piot C; Barrère-Lemaire S
    Circulation; 2007 Dec; 116(23):2709-17. PubMed ID: 18025529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
    Oerlemans MI; Liu J; Arslan F; den Ouden K; van Middelaar BJ; Doevendans PA; Sluijter JP
    Basic Res Cardiol; 2012 Jul; 107(4):270. PubMed ID: 22553001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiac dysfunction and endogenous cytokines in global ischemia and reperfusion injury].
    Kamikubo Y
    Hokkaido Igaku Zasshi; 1993 Nov; 68(6):813-26. PubMed ID: 8112707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion.
    Liu X; Xie W; Liu P; Duan M; Jia Z; Li W; Xu J
    Life Sci; 2006 Apr; 78(19):2255-64. PubMed ID: 16336978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lidocaine protects from myocardial damage due to ischemia and reperfusion in mice by its antiapoptotic effects.
    Kaczmarek DJ; Herzog C; Larmann J; Gillmann HJ; Hildebrand R; Schmitz M; Westermann A; Harendza T; Werdehausen R; Osthaus AW; Echtermeyer F; Hahnenkamp K; Wollert KC; Theilmeier G
    Anesthesiology; 2009 May; 110(5):1041-9. PubMed ID: 19352171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Platelet GPVI Protects Against Myocardial Ischemia-Reperfusion Injury.
    Pachel C; Mathes D; Arias-Loza AP; Heitzmann W; Nordbeck P; Deppermann C; Lorenz V; Hofmann U; Nieswandt B; Frantz S
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):629-35. PubMed ID: 26916731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.